目的研究DNA切除修复交叉互补基因组1(excision repair cross-complementation group 1,ERCC1)和着色性干皮病基因D/切除修复交叉互补基因组2((xerodenna pigmentosum group D/excisionrepair cross-complementation group 2,XPD/ERCC2...
详细信息
目的研究DNA切除修复交叉互补基因组1(excision repair cross-complementation group 1,ERCC1)和着色性干皮病基因D/切除修复交叉互补基因组2((xerodenna pigmentosum group D/excisionrepair cross-complementation group 2,XPD/ERCC2)的单核苷酸多态性(single nucleotidepolymorphisms,SNPs)与晚期非小细胞肺癌(nonsmall-cell lung cancer,NSCLC)患者的含铂类药
暂无评论